The virus that causes COVID-19 takes over the body’s fat-processing system and boosts cellular triglycerides as it causes disease.

The Department of Homeland Security Science and Technology Virtual First Responder Capitol Hill Showcase highlighted PNNL work in fentanyl detection standards and database libraries.

This PNNL-developed separation system quickly and successfully separates larger particles from smaller ones at various scales, in different solid-liquid mixtures and at different flow rates.

PNNL scientists have developed a new mass spectrometry method for in-depth analysis of proteins in individual cells.

The paper was recognized by the Society of Toxicology’s Medical Device and Combination Product Specialty Section.

PNNL and industry developing a faster, less expensive way to extract lithium for batteries used in cell phones and electric vehicles.

Proteomics revealed molecular mechanisms by which the drug Verapamil could prolong beta cell function in early-onset type 1 diabetes patients.

Study highlights microbiome’s role in regulating xenobiotic metabolism.

Tim Johnson has been selected for an open-ended term as associate editor of the Groundwater journal.

Recognizing how innovation and clean technologies at the very edge of the grid can work together to transition the electricity system, PNNL takes a multidisciplinary approach to advancing and integrating renewable energy solutions.

Development of a one-meter path length miniature ion mobility spectrometer based on multilevel structures for lossless ion manipulations.

Governor Inslee announced the appointment of Karin Rodland to the Board of Directors of the Andy Hill Cancer Research Endowment Fund.

Members of a geothermal energy collaboration go deep—real deep—to install a first-of-its kind system for evaluating interactions among water and rock.

The eighth Arab-American Frontiers of Science, Engineering, and Medicine Symposium, co-organized by PNNL engineer and research line manager Leonard Pease, brought together multi-disciplinary researchers from around the globe.

Studying MERS-CoV may lead to better treatments for a host of respiratory illnesses, including the many variants of COVID-19.

A study raises questions about how far droplets, like those that carry the virus that causes COVID-19, can travel before becoming harmless.

PNNL scientists are protecting first responders and others by expanding what’s known about fentanyl, the driver of the opioid epidemic.

PNNL chief chemical engineer Carlos Fernandez is a guest editor for a set of collection papers in Scientific Reports focusing on natural fibers.

Researchers characterize protein signatures that indicate Acute Kidney Injury in COVID-19 patients.

Simulations reveal advantages of using new model vs. allometric scaling for risk assessment.